Preclinical validation of 111In-girentuximab-F(ab′)2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts

Autor: Huizing, Fokko J., Hoeben, Bianca A.W., Franssen, Gerben, Lok, Jasper, Heskamp, Sandra, Oosterwijk, Egbert, Boerman, Otto C., Bussink, Johan
Zdroj: In Radiotherapy and Oncology September 2017 124(3):521-525
Databáze: ScienceDirect